|
|
|
Insider
Information: |
Luo Mary Z. |
Relationship: |
COO,Chief Scientist & ... |
City: |
Rancho Cucamonga |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
2,433,554 |
|
Indirect Shares
|
8,057,435 |
|
|
Direct
Value |
$102,574,301 |
|
|
Indirect Value
|
$339,620,885 |
|
|
Total
Shares |
10,490,989 |
|
|
Total
Value |
$442,195,186 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-07-02 |
4 |
D |
$15.39 |
$4,378,701 |
D/D |
(284,516) |
2,115,894 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-07-02 |
4 |
D |
$15.39 |
$2,554,248 |
I/I |
(165,968) |
1,366,706 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Science Officer |
|
2015-12-03 |
4 |
AS |
$15.42 |
$286,461 |
I/I |
(18,583) |
7,593,011 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-03-27 |
4 |
D |
$15.43 |
$133,331 |
I/I |
(8,641) |
661,666 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-03-27 |
4 |
D |
$15.43 |
$322,132 |
D/D |
(20,877) |
911,636 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Science Officer |
|
2015-12-01 |
4 |
AS |
$15.49 |
$309,780 |
I/I |
(20,000) |
7,611,594 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
OE |
$15.84 |
$8,154,163 |
D/D |
514,783 |
2,587,100 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
OE |
$15.84 |
$3,559,834 |
I/I |
224,737 |
1,591,443 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2017-09-13 |
4 |
D |
$15.86 |
$2,440,569 |
D/D |
(153,882) |
1,578,055 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2017-09-13 |
4 |
D |
$15.87 |
$1,912,398 |
I/I |
(120,504) |
1,076,833 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-05-16 |
4 |
B |
$16.06 |
$240,854 |
D/D |
15,000 |
2,080,619 |
3.23 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-05-15 |
4 |
B |
$16.08 |
$401,970 |
D/D |
25,000 |
2,065,619 |
3.23 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-09 |
4 |
AS |
$16.12 |
$415,971 |
I/I |
(25,800) |
673,524 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-12 |
4 |
AS |
$16.15 |
$1,221,132 |
D/D |
(75,618) |
919,271 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-12 |
4/A |
AS |
$16.15 |
$1,221,132 |
D/D |
(75,618) |
932,276 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-12 |
4 |
D |
$16.15 |
$123,295 |
D/D |
(7,635) |
911,636 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-12 |
4 |
AS |
$16.17 |
$621,972 |
I/I |
(38,471) |
665,418 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-12 |
4/A |
AS |
$16.17 |
$621,972 |
I/I |
(38,471) |
679,750 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-12 |
4 |
D |
$16.17 |
$60,660 |
I/I |
(3,752) |
661,666 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-09 |
4 |
D |
$16.23 |
$42,744 |
I/I |
(2,633) |
661,666 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-09 |
4 |
AS |
$16.24 |
$417,255 |
D/D |
(25,700) |
922,137 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-09 |
4 |
D |
$16.24 |
$42,602 |
D/D |
(2,624) |
911,636 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO and Chief Scientist |
|
2015-06-15 |
4 |
D |
$16.29 |
$76,239 |
D/D |
(4,679) |
911,636 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO and Chief Scientist |
|
2015-06-15 |
4 |
AS |
$16.29 |
$739,445 |
D/D |
(45,382) |
916,315 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-10 |
4/A |
AS |
$16.37 |
$186,820 |
I/I |
(11,411) |
674,732 |
0 |
- |
|
170 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|